June 8, 2017August 24, 2022
Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows
News
Patients with unresectable or metastatic melanoma who were treated with Keytruda (pembrolizumab) in a pivotal clinical trial showed superior and sustained time ... Read more
June 6, 2017
New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test
News
Castle Biosciences presented three abstracts on the validity of using its 31-Gene Expression Profile (GEP) Test for melanoma prognosis at the ... Read more
June 1, 2017June 2, 2017
Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer
News
Biothera Pharmaceuticals will present the detailed study design of the IMPRIME-1 clinical trial at the upcoming 2017 ASCO Annual Meeting June 2-6 in ... Read more
May 30, 2017
Researchers Provide New Insights into Melanoma Immune Resistance
News
A new study presents detailed information into the processes used by cancer cells to evade and resist the immune response. Researchers studied ... Read more
May 25, 2017May 25, 2017
New Clinical Trial Underway for Treatment of Advanced Melanoma
News
A new clinical trial is underway assessing the addition of the first-in-class AXL kinase inhibitor, BGB324, to standard of care treatment for patients with ... Read more
May 23, 2017May 23, 2017
Skin Cancer Awareness Month Brings Sun Safety to Schools
News
Educating people of all ages, particularly children, about the dangers of sun exposure is urgent to preventing the increased prevalence ... Read more
May 18, 2017
First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma
News
The first patient has been enrolled in Targovax‘s pilot clinical trial for advanced or unresectable melanoma patients whose cancer progressed after treatment ... Read more
May 16, 2017
ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial
News
The combination of ImmunoPulse IL-12 and the anti-PD-1 therapy Keytruda (pembrolizumab) soon will be tested in a Phase 2 trial for treatment ... Read more
May 11, 2017
Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial
News
Adding the small molecule MEK inhibitor binimetinib to the BRAF inhibitor encorafenib was safe and significantly prolonged the time to disease progression ... Read more
May 9, 2017May 9, 2017
Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize
News
The Pershing Square Sohn Cancer Research Alliance has announced the six winners of the fourth edition of the annual Pershing ... Read more
May 4, 2017
Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma
News
Castle Biosciences’ DecisionDx-Melanoma test can be used to accurately predict cancer recurrence and metastasis in patients with head and neck melanoma, ... Read more
April 25, 2017
IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group
News
Prima Biomed, an Australian biotechnology company developing immunotherapies for cancer and autoimmune diseases, announced it has received approval for the ... Read more

April 5, 2016April 7, 2016

Advanced Melanoma Combo Treatment, Opdivo/Yervoy, Gets a Positive Opinion from CHMP

News

The Committee for Medicinal Products for Human Use (CHMP) has released a positive opinion supporting the approval of Bristol-Myers Squibb‘s Opdivo (nivolumab), combined with Yervoy (ipilimumab), to treat adult patients with advanced (unresectable or metastatic) melanoma. The CHMP opinion also added a statement to ... Read more

March 31, 2016March 31, 2016

Immunocore Recruits 1st Uveal Melanoma Patient in Phase I Trial of Biological Drug, IMCgp100

News

Immunocore announced it has recruited the first patient for its Phase I monotherapy clinical trial of IMCgp100, its lead product candidate to treat uveal melanoma. Uveal melanoma is a cancer (melanoma) of the eye involving the iris, ciliary body, ... Read more

March 29, 2016March 29, 2016

Melanoma Study in Mice Uses a Microneedle Patch System to Effectively Deliver Immunotherapy

News

Despite advances in melanoma treatment, mainly as a consequence of anti-PD-1 (aPD1) immunotherapy, the approach still needs improvement. Now, North Carolina State University and the University of North Carolina at Chapel Hill ... Read more

March 24, 2016March 24, 2016

Multiple Gene Mutations Predict Recurrence in Malignant Melanoma and Clinical Outcomes, Study Suggests

News

In a new study, researchers investigated whether molecular profiling could predict clinical outcomes, and found that patients with primary malignant melanoma are at a higher risk of recurrent disease if they present ... Read more

March 22, 2016March 22, 2016

Melanoma Cells’ Transition from Benign to Malignant Mapped, and Reversed, in Yale Lab

News

The mechanism by which benign melanoma cells change into malignant ones is greatly affected by the cells’ stiffness, as determined by the specific balance of two signaling pathways — which, in turn, can ... Read more

March 17, 2016March 17, 2016

myPath Melanoma Test Shows 90% Accuracy in 2nd Trial, Company Reports at USCAP 2016

News

Myriad Genetics, Inc., recently released positive data from a second and pivotal clinical validation trial of its myPath Melanoma test in a poster presentation at the 2016 USCAP Annual Meeting in Seattle, Washington. “There is significant emotional distress associated ... Read more

March 15, 2016March 15, 2016

Study Links Increased Risk of Melanoma to Use of Sildenafil

News

Researchers have found that sildenafil — a drug used to treat erectile dysfunction and pulmonary hypertension — is linked to an increased risk of melanoma by promoting cGMP-cGKI signaling cascade. The ... Read more

March 10, 2016March 10, 2016

Researchers Identify Gene Linked to Growth of Melanoma, Possibly Leading to New Treatments

News

Yale researchers have discovered a gene associated with melanoma and its growth, which could pave the way for new therapeutics. The study, “DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 ... Read more

March 8, 2016May 17, 2016

Blood Test May Reveal Early Signs of Skin Cancer Relapse

News

A recent study published in Cancer Discovery has revealed that a blood test may give early alerts of a relapse in advanced melanoma patients. The study, titled “Application of sequencing, liquid biopsies and patient-derived xenografts ... Read more

March 3, 2016March 3, 2016

Melanomas Often Diagnosed in People with a Limited Number of Skin Moles, Study Reports

News

Nevi, or skin moles, are strongly associated with melanoma. But recent findings revealed that most melanoma patients have few and no atypical moles, and thick melanomas in people under age 60 are more often found in ... Read more

March 1, 2016March 1, 2016

New Malignant Melanoma Target Discovered by Yale Researchers

News

Researchers at Yale Cancer Center have discovered a gene that has a dramatic impact on the growth of melanoma. Their observations, titled ”DNMT3b Modulates Melanoma Growth by Controlling Levels of ... Read more

February 25, 2016February 25, 2016

Study Finds Link Between Melanoma and Parkinson’s Disease, Researchers Say

News

Recent findings indicate there may be a link between Parkinson’s disease and melanoma, with family history and common genetic susceptibility as possible causes. The review is published in the journal Dermatologic Surgery ... Read more

Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

Researchers Provide New Insights into Melanoma Immune Resistance

New Clinical Trial Underway for Treatment of Advanced Melanoma

Skin Cancer Awareness Month Brings Sun Safety to Schools

First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma

ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial

Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial

Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize

Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma

IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group